PGL 0.00% 85.0¢ prospa group limited.

So far it looks promising but the advanced melanoma market is of...

  1. 160 Posts.
    So far it looks promising but the advanced melanoma market is of course much smaller than for liver cancer.

    I would say there is a greater than 50% chance of failure if it gets to Phase III. Or should I say a more than 40% chance of success :-)
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.